Key result
Perioperative heparin-therapy inhibits late death from metastatic cancer.
Why the study?
Does perioperative low-dose heparin prophylaxis reduce three year mortality in postoperative patients?
Does perioperative low-dose heparin prophylaxis reduce three year mortality in postoperative patients?
Perioperative low-dose heparin prophylaxis is associated with a significant reduction in three-year mortality and death from disseminated malignancy in surgical patients.
No takes yet. Share an insight, caveat, or question.
May reduce late cancer mortality after surgery; leaves open confirmation by RCTs before practice change.
Kakkar et al. (1995) studied Metastatic cancer. Perioperative heparin-therapy was evaluated. Perioperative heparin-therapy inhibits late death from metastatic cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: